ERBB2 and invasive carcinoma: No significant correlations occurred between eIF4E expression and patients' age (p = 0.49), histological type in invasive carcinoma (p = 0.72), tumor size (p = 0.25), node metastasis (p = 0.23), TNM stage (p = 0.54), or the ER, PR, and HER-2 status provided (p = 0.44, p = 0.38, and p = 0.45, respectively) (Table 2).